TREACE MEDICAL CONCEPTS, INC.

TMCI

TREACE MEDICAL CONCEPTS, INC.

TMCI

Insider Sentiment (TTM):

Last Purchase:2026-06-11Last Sale:2025-03-17Shares Purchased (TTM):182,843Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:34,597,252Shares Outstanding:64,592,681Institutional Ownership Pct.:53.56%

Earnings Market Reaction:

Filing Date:2026-08-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	13	10	11	8	8	13	11	12	18	9	13	7
Marketable Securities Current	33	42	38	50	61	63	64	71	77	101	110	115
Accounts Receivable Net Current	29	30	42	33	30	31	41	24	26	30	38	25
Inventory Net	40	36	36	41	42	38	39	44	41	36	29	29
Prepaid Expense And Other Assets Current	7	5	6	6	6	4	6	7	10	11	8	11
Assets Current	120	123	132	138	148	149	161	158	172	187	198	187
Property Plant And Equipment Net	32	32	30	30	30	27	26	25	24	25	22	22
Intangible Assets Net Excluding Goodwill	7	7	7	7	8	8	8	8	9	9	9	9
Goodwill	13	13	13	13	13	13	13	13	13	13	13	13
Operating Lease Right Of Use Asset	7	7	8	8	8	8	8	9	9	9	9	9
Other Assets Noncurrent	2	1	1	1	1	0	0	0	0	0	0	0
Assets	181	184	191	197	206	206	217	213	226	243	252	240
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	16	14	7	16	20	13	11	19	18	21	12	9
Accrued Liabilities Current	6	6	6	7	6	6	7	8	14	15	10	9
Employee Related Liabilities Current	8	6	6	7	7	5	7	6	6	4	8	5
Liabilities Current	41	34	31	41	42	33	35	38	44	47	45	33
Long Term Debt Noncurrent	56	56	56	54	53	53	53	53	53	53	53	53
Operating Lease Liability Noncurrent	13	14	14	13	13	14	16	16	16	16	16	16
Other Liabilities Noncurrent	3	3	3	0	0	0	0	0	0	0	0	0
Liabilities	113	107	103	107	109	101	104	108	114	116	114	103
Commitments And Contingencies	-	-	-	-	-	-	-	-	-	-	-	0
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	352	345	337	330	322	312	303	294	286	279	272	266
Retained Earnings Accumulated Deficit	-283	-267	-249	-240	-223	-206	-190	-189	-174	-153	-134	-128
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	0	0	0	-0	0	0	-0
Treasury Stock Value	-1	-1	-1	-1	-1	-1	-0	-0	-0	-0	-0	-
Stockholders Equity	68	77	87	89	98	105	113	105	112	126	138	138
Liabilities And Stockholders Equity	181	184	191	197	206	206	217	213	226	243	252	240
Allowance For Doubtful Accounts Receivable Current	2	2	2	2	2	1	1	1	1	1	1	1
Finite Lived Intangible Assets Accumulated Amortiz…	3	3	2	2	2	2	1	1	1	1	0	0
Debt Instrument Unamortized Discount Premium And D…	-	-	4	-	-	-	1	1	1	1	1	1
Other Receivable Allowance For Credit Loss Noncurr…	0	0	0	-	-	-	0	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0	0.001	0.001	0.001	0	0.001	0.001	0.001	0	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0	0.001	0.001	0.001	0	0.001	0.001	0.001	0	0.001
Preferred Stock Shares Outstanding	-	-	0	-	-	-	0	0	0	0	0	0
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Common Stock Shares Issued	65	65	64	64	63	63	62	62	62	62	62	62
Shares Outstanding	-	-	-	-	-	-	-	62	62	62	62	62
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	72.14%	121.89%	99.00%	-	-	-	-	-	-	-	-	-
2025	-23.87%	-23.74%	-24.40%	29.23%	17.25%	20.95%	-52.17%	-61.16%	-58.59%	-33.33%	4.30%	43.01%
2024	-47.12%	-40.20%	-30.58%	-7.36%	-13.36%	-29.58%	47.92%	21.18%	60.07%	-9.64%	-29.35%	-26.40%
2023	-	-	-	-9.69%	-23.96%	-44.90%	-6.90%	27.50%	28.20%	-15.44%	-23.71%	-65.23%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.90	3.58	4.31	3.37	3.52	4.50	4.62	4.12	3.86	3.98	4.40	5.64
Quick Ratio	1.79	2.38	2.95	2.21	2.38	3.23	3.34	2.80	2.71	2.98	3.58	4.44
Working Capital	78.96M	88.98M	101.42M	97.09M	105.70M	116.26M	126.48M	119.34M	127.11M	140.35M	153.33M	153.99M
Leverage & Debt
Debt to Equity	1.67	1.39	1.18	1.20	1.11	0.95	0.92	1.03	1.02	0.92	0.83	0.74
Interest Coverage TTM	-9.23	-9.99	-10.18	-9.17	-9.11	-9.96	-10.60	-11.87	-12.42	-10.89	-9.95	-9.30
Debt Ratio	0.63	0.58	0.54	0.55	0.53	0.49	0.48	0.51	0.50	0.48	0.45	0.43
Efficiency & Turnover
Asset Turnover TTM	1.06	1.06	1.04	1.07	0.99	0.94	0.89	0.90	0.83	0.80	0.91	0.88
Days Sales Outstanding TTM	52.50	54.11	71.18	47.64	47.72	52.97	68.75	44.24	48.53	51.62	65.60	45.49
Receivables Turnover TTM	6.95	6.75	5.13	7.66	7.65	6.89	5.31	8.25	7.52	7.07	5.56	8.02
Per Share Metrics
Diluted EPS TTM	-0.91	-0.95	-0.93	-0.79	-0.78	-0.85	-0.90	-0.99	-1.03	-0.89	-0.81	-0.77
Free Cash Flow Per Share TTM	-0.47	-0.40	-0.47	-0.43	-0.47	-0.59	-0.79	-0.69	-0.67	-0.62	-0.76	-0.84
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	79.45%	79.72%	79.81%	79.87%	80.12%	80.25%	80.37%	80.61%	80.67%	80.99%	81.20%	81.26%
Operating Profit Margin TTM	-26.17%	-26.89%	-25.46%	-22.13%	-22.41%	-24.81%	-26.60%	-30.69%	-32.71%	-28.88%	-27.48%	-27.56%
Net Profit Margin TTM	-28.99%	-29.44%	-27.74%	-22.89%	-23.01%	-25.13%	-26.63%	-30.33%	-32.08%	-27.93%	-26.47%	-27.28%
Growth Metrics
Net Revenue Growth (1Y)	-3.95%	-1.66%	1.59%	7.90%	7.67%	7.54%	11.89%	16.14%	18.90%	26.48%	31.92%	39.17%
Net Income Growth (1Y)	21.01%	15.20%	5.85%	-18.55%	-22.77%	-3.21%	12.55%	29.09%	50.66%	15.91%	15.68%	6.32%
EPS Growth (1Y)	17.21%	11.75%	3.91%	-20.20%	-23.91%	-4.56%	10.27%	27.71%	48.96%	10.16%	5.08%	-4.27%
Valuation Metrics
P/E TTM	-4.35	-1.42	-2.63	-8.51	-7.53	-9.92	-8.29	-5.87	-6.48	-14.73	-15.67	-16.93
P/B TTM	3.82	1.12	1.77	4.78	3.80	4.99	4.09	3.44	3.68	6.38	5.62	5.85
P/S TTM	1.26	0.42	0.73	1.95	1.73	2.49	2.21	1.78	2.08	4.11	4.15	4.62
Market Cap	258.90M	86.55M	155.01M	426.19M	370.48M	525.73M	462.11M	360.93M	412.84M	806.40M	775.86M	807.08M
Enterprise Value	302.33M	132.83M	199.88M	472.03M	415.88M	565.74M	504.07M	402.05M	447.82M	850.14M	815.89M	852.74M
Calculated Values
Free Cash Flow TTM	-30.29M	-25.96M	-29.49M	-27.00M	-29.80M	-36.96M	-48.76M	-43.20M	-41.50M	-38.44M	-46.03M	-52.01M
Net Debt	43.43M	46.28M	44.88M	45.84M	45.40M	40.01M	41.96M	41.12M	34.98M	43.75M	40.03M	45.66M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-11Purchase

Owner: Treace, John T.

Title: Chief Executive Officer

Shares: 9,891

Price/Share: $4.04

Value: $39,959.64

Shares Owned: 7,348,439

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2026-06-01Purchase

Owner: Treace, John T.

Title: Chief Executive Officer

Shares: 50,000

Price/Share: $3.56

Value: $178,000.00

Shares Owned: 7,323,833

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2026-05-28Purchase

Owner: Treace, John T.

Title: Chief Executive Officer

Shares: 61,202

Price/Share: $3.02

Value: $184,830.04

Shares Owned: 7,273,833

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2026-05-14Purchase

Owner: Treace, John T.

Title: Chief Executive Officer

Shares: 61,750

Price/Share: $2.62

Value: $161,785.00

Shares Owned: 7,158,313

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2025-03-17Sale

Owner: Scanlan, Sean F.

Title: Chief Innovation Officer

Shares: 50,000

Price/Share: $7.97

Value: $398,500.00

Shares Owned: 364,081

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-11	Treace, John T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	9,891	4.04	$39,959.64	7,348,439	4/A
2026-06-01	Treace, John T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	50,000	3.56	$178,000.00	7,323,833	4
2026-05-28	Treace, John T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	61,202	3.02	$184,830.04	7,273,833	4
2026-05-14	Treace, John T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	61,750	2.62	$161,785.00	7,158,313	4
2025-03-17	Scanlan, Sean F.	Officer	Chief Innovation Officer	Direct	Sale	50,000	7.97	$398,500.00	364,081	4
2025-03-04	Treace, John T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	60,000	8.73	$523,800.00	6,796,190	4
2024-09-16	Treace, John T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	50,000	5.31	$265,500.00	6,523,095	4
2024-08-15	Treace, James T	Director	-	Direct	Purchase	84,000	5.96	$500,640.00	1,223,441	4
2024-08-14	Treace, John T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	85,000	6.00	$510,000.00	6,473,095	4
2024-06-11	Treace, John T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	45,000	5.88	$264,600.00	6,388,095	4
2024-05-31	Treace, James T	Director	-	Direct	Purchase	25,000	6.05	$151,250.00	1,139,441	4
2024-05-29	Treace, James T	Director	-	Direct	Purchase	25,000	5.20	$130,000.00	1,114,441	4
2024-05-28	Treace, James T	Director	-	Direct	Purchase	50,000	5.07	$253,500.00	1,089,441	4
2024-05-24	Mott, Richard W	Director	-	Direct	Purchase	18,000	5.19	$93,420.00	1,072,944	4
2024-05-22	Mott, Richard W	Director	-	Direct	Purchase	12,100	4.99	$60,379.00	1,054,944	4
2024-05-17	Treace, John T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	100,000	5.56	$556,000.00	6,343,095	4
2024-05-14	Kiernan, Jane E	Director	-	Direct	Purchase	19,356	5.17	$100,070.52	24,941	4
2024-05-14	Treace, John T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	150,000	5.12	$768,000.00	6,243,095	4
2024-05-13	Treace, John T.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	150,000	4.56	$684,000.00	6,093,095	4
2024-05-13	Treace, James T	Director	-	Direct	Purchase	145,000	4.54	$658,300.00	1,039,441	4
2024-05-13	Mott, Richard W	Director	-	Direct	Purchase	36,802	4.38	$161,192.76	1,027,753	4
2024-05-10	Bakewell, John K	Director	-	Direct	Purchase	130,000	4.57	$594,100.00	135,048	4
2024-05-10	Jain, Deepti	Director	-	Direct	Purchase	25,000	4.50	$112,500.00	31,235	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

53.56%

Inst. Shares: 34,597,252

Shares Outstanding: 64,592,681

2025-12-31

54.68%

Inst. Shares: 34,598,343

Shares Outstanding: 63,269,003

2025-09-30

88.84%

Inst. Shares: 56,428,941

Shares Outstanding: 63,515,372

2025-06-30

59.70%

Inst. Shares: 37,616,517

Shares Outstanding: 63,006,891

2025-03-31

59.36%

Inst. Shares: 37,194,263

Shares Outstanding: 62,661,447

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	34,597,252	64,592,681	53.56%
2025-12-31	34,598,343	63,269,003	54.68%
2025-09-30	56,428,941	63,515,372	88.84%
2025-06-30	37,616,517	63,006,891	59.70%
2025-03-31	37,194,263	62,661,447	59.36%
2024-12-31	36,652,473	62,112,037	59.01%
2024-09-30	38,269,315	62,229,463	61.50%
2024-06-30	38,878,819	62,081,494	62.63%
2024-03-31	38,900,172	61,792,788	62.95%
2023-12-31	38,836,041	60,852,153	63.82%
2023-09-30	35,295,063	61,562,494	57.33%
2023-06-30	35,242,754	61,382,514	57.41%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

TREACE MEDICAL CONCEPTS, INC. (TMCI) — SEC Financial Statements & Analysis

TREACE MEDICAL CONCEPTS, INC. (TMCI) is a surgical & medical instruments & apparatus company, incorporated in FL. TREACE MEDICAL CONCEPTS, INC. trades on Nasdaq as: TMCI. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), TREACE MEDICAL CONCEPTS, INC. reported a -3.95% year-over-year revenue growth, a Gross Profit Margin of 79.45% (TTM), a Debt-to-Equity ratio of 1.67x, a Price-to-Sales (P/S) ratio of 1.26x (TTM), a Price-to-Book (P/B) ratio of 3.82x (TTM), at a market cap of $258.90M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -3.95%
Gross Profit Margin TTM: 79.45%
Debt To Equity: 1.67x
P/S TTM: 1.26x
P/B TTM: 3.82x
Market Cap: $258.90M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is TREACE MEDICAL CONCEPTS, INC. in?

TREACE MEDICAL CONCEPTS, INC. (TMCI) operates in the Surgical & Medical Instruments & Apparatus industry.

What is TMCI's market cap?

TREACE MEDICAL CONCEPTS, INC. (TMCI) has a market capitalization of $258.90M as of 2026-06-30.

What exchange does TMCI trade on?

TREACE MEDICAL CONCEPTS, INC. (TMCI) trades on the Nasdaq.

Where is TREACE MEDICAL CONCEPTS, INC. incorporated?

TREACE MEDICAL CONCEPTS, INC. is incorporated in FL.